Ziegler Capital Management’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
AIM
FAM
ACH
BG
Ziegler Capital Management's CDNA Position: Q2 2022 in Review
Ziegler Capital Management sold out of CareDx (CDNA) in Q2 2022, closing a stake of 149,041 shares — an estimated $5.51M sold.
Ziegler Capital Management first reported a position in CDNA in Q1 2020 and held it in 9 quarters. The position peaked at $16.8M in Q4 2020. 184 funds tracked by Wall St. Rank hold CDNA as of Q2 2022.
- Ziegler Capital Management reported no remaining CareDx position as of Q2 2022 after selling out during the quarter.
- Ziegler Capital Management sold 149,041 CareDx shares in Q2 2022, an estimated $5.51M.
- Ziegler Capital Management first reported a position in CareDx in Q1 2020 and held it in 9 quarters.
- Ziegler Capital Management's CareDx position peaked at $16.8M in Q4 2020.
- 184 funds tracked by Wall St. Rank held CareDx as of Q2 2022.
Based on Ziegler Capital Management's 13F filing for Q2 2022, filed 21 Jul 2022.